The in vitro incorporation and transport of plasma nonesterified fatty acids into phospholipids of red cell membranes have been studied in cystic fibrosis and healthy children.
clusion of that study (8) is that the fatty acid composition of the plasma cholesterol esters of CF patients without pancreatic insufficiency is significantly different from the results obtained for agematched controls (8) . Furthermore, it was found that the fatty acid patterns of the various phospholipid fractions of the RBC membranes are abnormal in CF patients with pancreatic insufficiency (24) . A positive correlation was observed between the fatty acid changes of both plasma and RBC phospholipid fractions (Rogiers, V., unpublished data).
One of the mechanisms, playing a major role in the continuous in vivo renewal of RBC lipids consists of the active incorporation of plasma NEFA's into the phospholipids of the RBC membrane (28, 29) . Consequently it is possible that this process could be partly responsible for the abnormalities observed in the RBC membranes of CF patients. On the other hand, abnormal fatty acid patterns intrinsic to the C F membranes could support the hypothesis of a possible defect in fatty acid metabolism.
In order to obtain more information concerning the active incorporation process of plasma NEFA's into the phospholipids of the RBC membranes of CF patients, a number of incorporation and reincubation experiments with labeled NEFA's have been carried out. RBCs of healthy and CF children were incubated with [14C1-linoleic and [3H1-palmitic acid bound to albumin. The labeled RBC'S were reincubated in their autologous serum.
Speculation
In this study, the theoretical approach proposed by Shohet (28, 29) is used ( Fig. 1) . The assumption is made that the incorporated It is possible that the primary defect in cystic fibrosis is caused NEFA's are all taken up into phosphatidyl choline (PC) before by an alteration in membrane structure and function. Perhaps the their transfer into phosphatidyl ethanolamine (PE) and their final increased turnover of erythrocyte fatty acids in cystic fibrosis release into the serum. This reasoning is not completely correct, patients is related to this membrane defect.
but it allows to study separately the incorporation of both labeled fatty acids into the ~d and the PE friction. If however, it is assumed that plasma NEFA's are incorporated independently into The acid patterns of the lipid fractions of plasma (9, both PC and PE by the same reaction catalysed by acyltransferase, 23)7 platelets (20) , red (RBC) (4, 7, 14, 24) , the final conclusions of this study remain the same. In that case, tissue '1, mucous (27) , and 'puturn (26) 'ystic the results shown in Figures Za, b and Figures 4a, b represent the fibrosis (CF) patients are changed in comparison with the corre-incorporation of both labeled fatty acids into the combined PC sponding patterns of healthy subjects.
Some investigators have attributed these modifications to mal-A possible influence of the transmethylation pathway in which absorption, occurring in CF patients with pancreatic insufficiency pE is transformed into PC via monomethyl and dimethyl phos-(9, lo). Others, have suggested a possible defect in fatty phatidyl ethanolamine need not to be taken into account in the acid (I9, 20). The Our previous research calculations presented in this study. The activity of the enzymes, the latter as it showed that responsible for this conversion, is highest in liver microsomes, but acid patterns can occur in both CF patients with and without it is still the minor pathway in this tissue for the synthesis of PC pancreatic insufficiency (8, 23) . Abnormal fatty acid patterns have (32) . Calculations, reported in the literature, show that in erythbeen found for the nonesterified fatty acid (NEFA) fraction of the rocytes the enzymatic activity just mentioned is only O.l% of that C F patients without pancreatic insufficiency studied (23) . As this observed in liver microsomes (34) . fraction could be more variable than the other plasma lipids, the fatty acid patterns of the plasma cholesterol ester fractions have MATERIALS AND METHODS been analysed for CF patients without clinical evidence of pancreatic difficulties (8) . These fatty acid patterns were abnormal Materials. Materials, used for the analysis of the individual too, although to a lesser extent than the corresponding patterns of phospholipid fractions of the RBCs, were described previously CF patients with pancreatic insufficiency. Nevertheless the con-(22). (28, 29) . NEFA, nonesterified fatty acids; ALB, albumin; F,, superficial pool of NEFA's; Fp, deeper membrane pool; PC, phosphatidyl choline; PE, phosphatidyl ethanolamine; LPC, lyso-PC, LPE, lyso-PE; -, passive exchange; and -+, active exchange. Scintillation cocktails Carbosorb-Permafluor V (1/3; v/v), Monophase 40 and Instagel I1 were obtained from Packard Instrument Co. Krebs-Henseleit buffer was prepared as described elsewhere (33) . Penicillin and streptomycin sulfate were purchased from Continental Pharma.
Blood collection. Twenty ml and 50 ml venous blood samples were needed respectively for the incorporation and the reincubation experiment. Blood was collected with sodium citrate from four CF patients (two females and two males, 8-10 years old) with pancreatic insufficiency and from four healthy children of the same age and sex after an overnight fast of 12 h.
In vitro experiments: incorporation experiment. Twenty ml blood are centrifuged at 250 x g for 10 min at room temperature. White I n vitro experiments: reincubation experiment, Fifty ml blood are washed and the RBCs are incubated with radioactively labeled fatty acids for two h as described in "In vitro experiments: incorporation experiment." Eight ml packed RBCs are then resuspended in 8 ml autologous serum for 5 min at 37OC in order to restore the normal surface pool of nonradioactive fatty acids. The serum is removed by centrifugation. Seven ml of the radioactively labeled RBC suspension are then reincubated in 10.5 ml autologous serum to which 34.5 mg glucose; 59.1 mg ATP; 5.9 mg CoA SH; 1.5 mg penicillin and 1.5 mg streptomycin sulfate are added. At various time intervals, aliquots are taken and centrifuged. RBCs are washed and stored with dithionite at -20°C. The next day lipid extracts are made and stored under N2 at -20°C for maximum 2 months.
Lipid analysis. The individual phospholipid fractions of the RBCs are analysed as described recently (22) . In short, total lipids are extracted by the method of Rose and Oklander (25). The total extract is then purified by partition-chromatography on Sephadex G 25 coarse and the phospholipids are separated by two dimensional thin layer chromatography (in duplicate). One thin layer chromatographic plate is used for the phosphorus determination of the PC, PE and sphingomyelin (SPm) spots by the method of Bartlett (1) . The second thin layer chromatographic plate is used for radioactivity determinations of the PC and PE spots and a phosphorus determination of the SPm spot. The phospholipid composition of the erythrocyte membranes is as published before (24) . Namely, the relative concentration of PC and PE is 27% for both groups of children. The fatty acid composition of the plasma NEFA fraction and of the individual phospholipids is determined as described previously (21, 22 
RESULTS
The results are expressed in dpm/pmole SPm. The latter lipid fraction is used as an internal standard because it is not involved ,in the NEFA exchange mechanism. Its concentration in the RBC is the same for both CF and healthy children and remains constant during the incorporation and the reincubation process as experimentally determined. The results are statistically analysed using the Student's t test (two-tailed) according to Snedecor and Cochran (3 1).
Incorporation experiment: phosphadityl choline. The incorporation of labeled [14C]-linoleic acid into PC is shown in Figure 2a and of [3H]-palmitic acid in Figure 2b . The term "incorporation into PC" means the radioactivity that is present in PC plus the one already transferred from PC into PE. From these graphs it appears that during a given period of time more net counts of both labeled fatty acids accumulate in the PC fraction of the erythrocytes for the CF patients than for the healthy children (for t = 3 h, P < 0.001). The difference observed is not due to variation of the PC concentration because it was found that during the whole experiment the concentration of PC in the RBC membrane remained constant for healthy children and for CF patients.
The ratio of incorporated [3H]-palmitic acid into PC versus -palmitic acid into PE. The incorporation rate of both fatty acids into PE is significantly higher for CF patients than for healthy children (for t = 3 h, P < 0.001). The PE concentration was measured at each time interval. The difference observed is not due to a different concentration of PE for C F and healthy erythrocytes.
The ratio of incorporated [3H]-palmitic acid into PE versus incorporated [14C]-linoleic acid is the same for both healthy and C F children.
Reincubation experiment: phosphatidyl choline. During the reincubation of labeled RBC's in autologous serum, the uptake of both labeled fatty acids from a deeper membrane pool of NEFA's into PC continues. This is shown in Figure 4a and b. The ordinate represents the sum of the radioactivities present in PC, in PE, and in the serum. The units are expressed in dpm PC/ml RBC. dpm PC/ml RBC = dpm PC/pmole SPm X Csp, CSP,,, represents the mean concentration of SPm in 1 ml of RBC suspension, which is the same for CF and healthy children.
From both graphs it appears that for CF children the in vitro uptake of [14C]-linoleic and [3H]-palmitic acid into PC continues throughout the experiment. For healthy ones this uptake stops after 7 h of reincubation.
At the start of the experiment the net uptake of both labeled fatty acids into PC is higher for CF patients than for healthy children as could be predicted by the results of the incorporation experiment, phosphatidyl ethanolamine (for t = 0 h, P < 0.01).
The in vitro uptake of both fatty acids into PC is at every time interval significantly higher in CF children than in healthy ones (for t = 19 h, P < 0.001); however, the starting conditions of the reincubation experiment are different for both groups of children, due to their different behaviour during the previous incorporation step (Fig. 2) . When the relative incorporation rate per time interval (At) is calculated, which means that the uptake of labeled fatty acids into PC at t = 0 for CF and healthy children is equalized to one, the same conclusion can still be drawn (Fig. 5a and 5b) . It is clear that starting from t = 7, the relative incorporation rate per time interval of both labeled fatty acids is higher for CF children than for healthy ones (for t = 7 h, P < 0.001).
Reincubation experiment: phosphatidyl ethanolamine. In Figure  6a and b, the in vitro uptake of both labeled fatty acids into the erythrocyte PE fraction is shown. Here again the units are expressed as dpm PE/ml. RBC = dpm PE/pmole SPm x Csp,,,.
Because these graphs are equivalent to those represented in Figure  4a and b, the same conclusions can be drawn. Namely, the transfer of labeled linoleic and palmitic acid from PC into PE is significantly higher for CF cells than for healthy ones (for t = 3 h, P <
0.001).
Reincubation experiment: serum. The in vitro release of [14C]-linoleic and [3H]-palmitic acid from the RBCs into autologous serum goes on during the whole experiment (Fig. 7a and b) . At every moment the release of both fatty acids into serum is significantly higher for CF children than for healthy ones (from t = 3 h, P < 0.001).
When the relative release rate per time interval of both fatty acids into serum is calculated and when the differences in starting positions between CF and healthy RBCs are normalized, it appears that the relative release rate becomes fairly constant after 3 h of reincubation. The relative release rate remains higher for CF patients than for healthy children (for linoleic acid from t = 7 h, P < 0.001 and for palmitic acid, P < 0.01). both labeled fatty acids are incorporated into PC, transferred into PE and released into the serum at the same rate for both groups of children, the ratio of incorporated [3H]-palmitic versus [14C]-linoleic acid is calculated (Fig. 8) . The different starting conditions are taken into account. The curves obtained for CF and healthy children have the same shape for the RBC PC and PE fractions and for the serum lipids. The curve for healthy children is situated above the one for CF patients (Fig. 8) . At t = 0 this difference already exists (P < 0.05).
Reincubation experiment: exchange of ['H~'-~almitic versus ['4C]-linoleic acid. In order to answer the question whether or not
It is maintained throughout the experiment. At t = 0, more labeled linoleic acid versus palmitic acid is present in the serum of CF patients in comparison with healthy children. In other words, CF erythrocytes retain in their membranes more palmitic than linoleic acid.
DISCUSSION
The incorporation experiment is run under nearly identical conditions as described by Shohet et al. (30) . Glucose, ATP and CoA SH are added to the incubation medium to stimulate the incorporation of NEFAs into the RBC membranes. The consumption of glucose is fairly constant and is 4 mg% per h for both groups of children.
The incorporation of both labeled fatty acids into the PC and PE fractions of the RBC membranes is going on with a constant rate for only 2 h for healthy children (Fig. 2a, b and 3a, b) . This observation is in agreement with the results of Oliveira and Vaughan (17 that for healthy subjects the incorporation slows down after about 3 h. For CF patients we have found that this incorporation process continues at the same rate (Fig. 2a, b and 3a, b) ; however, results of similar work for C F patients do not exist in the literature.
During the whole experiment, the incorporation rate of both labeled fatty acids is higher for CF patients than for healthy children. Four explanations can be put forward.
(1) It is possible that a difference in pool size Fz exists between C F and healthy RBCs. More information concerning the nature and the size of this deeper membrane pool will be obtained in further experiments.
(2) Lyso-PC, needed for the acyltransferase reaction, could be available in higher concentration in CF cells than in healthy ones. Perhaps lecithin cholesterol acyltransferase might play an important role in the formation of more lyso-PC.
(3) The activity of the various enzyme systems, involved in the active incorporation process, may have changed in C F cells in comparison with healthy ones. (4) The plasma concentration of vitamin E may be an important factor. It has been reported that the turnover of RBC fatty acids can change when membrane polyunsaturated fatty acids are exposed to higher peroxidation, as in vitamin E deficiency (12, 16). Furthermore the life-span of erythrocytes can be shortened in the case of vitamin E deficiency (7); however, the CF patients examined were supplemented with vitamin E and it is reported that the effects, just This assumption can be checked by analysing the ratio of incorporated [3H]-palmitic versus ['4C]-linoleic acid present at every moment in PC and PE. This means that the radioactivity that is really present in every spot on the TLC plate is taken into account and not the sum of radioactivities as represented in all the graphs, shown in this paper. It is found that the ratio of incorporated [3H]-palmitic versus ['4C]-linoleic acid is indeed higher for CF patients than for healthy subjects. This is true for both the PC (for t = 0 and 19 h, P < 0.05) and PE (for t = 0, P < 0.01 and for t = 19 h, P < 0.001) fractions. Because the ratio mentioned remains constant during the whole experiment, the difference between both groups of children is again o b s e~a b l e from the beginning of the experiment.
An acceptable explanation for this observation is the fact that the in vivo fatty acid patterns of the various RBC phospholipid fractions are abnormal in C F patients with pancreatic insufficiency in comparison with healthy children (24) . Namely the % concentration of palrnitic acid is higher and that of linoleic acid lower in RBCs of C F patients. This means that the % of exchangeable molecules of palmitic versus linoleic acid is significantly higher for the PC and PE fractions of C F patients in comparison with healthy subjects.
Consequently we could expect the in vitro ratio of labeled palmitic versus linoleic acid in this experiment to be higher in CF children than in healthy ones. We can conclude that no difference could be detected between the in vitro incorporation, transfer and release of labeled palmitic acid versus linoleic acid in CF children, compared with healthy ones. During this 19-h experiment, the fatty acid compositions of the RBC phospholipids remain unchanged.
The increased in vitro turnover of both labeled fatty acids in the RBCs of CF patients can be intrinsic to the membrane but may also be caused by extrinsic serum factors. In this study no experiments with standardised serum have been performed in order to try to isolate intrinsic from extrinsic effects. The amount of blood taken from one CF child would have been too high to carry out experiments with autologous and homologous serum simultaneously. In further experiments we will try to answer this question. These experiments may show whether our hypothesis is right or wrong.
If the altered fatty acid composition of the RBCs (24) or the changed turnover of these fatty acids is related to the basic defect in CF, one would hope to be able to detect the same abnormalities in other body fluids and tissues:
(1) Abnormal fatty acid patterns have already been described for the lipids of plasma (2, 9, 10, 23), platelets (20) , adipose tissue (1 I), bronchial mucus (27) , and sputum (26) 
